Get started
Author

Mary J. G. van Helden

Observed names: M.V. Helden, Mary J G van Helden, Mary J van Helden, Mary J. Van Helden, Mary J. van Helden, Mary J.G. van Helden, Mary JVan Helden, Mary van Helden
Observed institutions: Utrecht University, Ghent University Hospital, Vlaams Instituut voor Biotechnologie, Ghent University, VIB-UGent Center for Inflammation Research, Byondis BV (Netherlands)
ORCID: 0000-0002-4506-4943
Observed ORCID: 0000-0002-4506-4943
OpenAlex ID: A5049280888
FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry data
2015 · Sofie Van Gassen, Britt Callebaut, et al. · Cytometry Part A · 1,938
Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection
2020 · Cedric Bosteels, Katrijn Neyt, et al. · Immunity · 429
PDF
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
2017 · Margherita Coccia, Catherine Collignon, et al. · npj Vaccines · 277
PDF
Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection
2015 · Mary J. van Helden, Steven Goossens, et al. · The Journal of Experimental Medicine · 186
PDF
Mouse Models of Asthma
2016 · Nincy Debeuf, Eline Haspeslagh, et al. · Current Protocols in Mouse Biology · 83
PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I‐binding peptides in vivo
2011 · Natascha de Graaf, Mary J. G. van Helden, et al. · European Journal of Immunology · 68
CCR2 Defines a Distinct Population of NK Cells and Mediates Their Migration during Influenza Virus Infection in Mice
2012 · Mary J. G. van Helden, Dietmar M. W. Zaiss, et al. · PLoS ONE · 66
PDF
Dendritic cells in asthma
2013 · Mary J van Helden, Bart N Lambrecht · Current Opinion in Immunology · 65
The Bone Marrow Functions as the Central Site of Proliferation for Long-Lived NK Cells
2012 · Mary J G van Helden, Natascha de Graaf, et al. · The Journal of Immunology · 45
The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF
2019 · Jessica Vetters, Mary J. van Helden, et al. · The Journal of Experimental Medicine · 39
PDF
Role of NKp46+ natural killer cells in house dust mite‐driven asthma
2018 · Eline Haspeslagh, Mary J van Helden, et al. · EMBO Molecular Medicine · 28
PDF
BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells
2023 · Mary J van Helden, Seline A Zwarthoff, et al. · Journal for ImmunoTherapy of Cancer · 25
PDF
Pre-existing virus-specific CD8+ T-cells provide protection against pneumovirus-induced disease in mice
2012 · Mary J.G. van Helden, Peter J.S. van Kooten, et al. · Vaccine · 17
PDF
Epitope mapping and kinetics of CD4 T cell immunity to pneumonia virus of mice in the C57BL/6 strain
2017 · Lana Vandersarren, Cedric Bosteels, et al. · Scientific Reports · 11
PDF
Immunoproteasome-Deficiency Has No Effects on NK Cell Education, but Confers Lymphocytes into Targets for NK Cells in Infected Wild-Type Mice
2011 · Mary J. G. van Helden, Natascha de Graaf, et al. · PLoS ONE · 8
PDF
Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes
2012 · Maryam Amidi, Mary J.G. van Helden, et al. · Journal of Controlled Release · 7
Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
2018 · Margherita Coccia, Catherine Collignon, et al. · npj Vaccines · 5
PDF
Canonical IRE1 function needed to sustain vigorous natural killer cell proliferation during viral infection
2022 · Jessica Vetters, Mary van Helden, et al. · iScience · 4
The Mucosal Immune Response to Respiratory Viruses
2015 · Bart N. Lambrecht, Katrijn Neyt, et al. · Elsevier eBooks · 2
Abstract 6921: Phosphonate-antibody-drug conjugates, a novel immunostimulatory class of ADCs driving inside-out activation of Vγ9Vδ2 T cells leading to selective tumor cell killing
2026 · Mary J. van Helden, Genny Filliciotto, et al. · Cancer Research · 1
129P BYON4228 is a pan-allelic SIRPα antibody that potentiates killing of antibody-opsonized tumor cells and lacks binding to T-cells
2021 · M.V. Helden, S. Zwarthoff, et al. · Annals of Oncology · 1
Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection
2015 · Mary J. van Helden, Steven Goossens, et al. · The Journal of Cell Biology · 1
954 Phosphonate-antibody-drug conjugates: a novel immunostimulatory class of ADCs driving inside-out activation of Vγ9Vδ2 T cells leading to selective tumor cell killing
2025 · Mary JVan Helden, Genny Filiciotto, et al. · Journal for ImmunoTherapy of Cancer
PDF
1160 Phosphonate-antibody-drug conjugates: a novel immunostimulatory class of ADCs driving inside-out activation of Vγ9Vδ2 T cells leading to selective tumor cell killing
2023 · Mary J van Helden, Ronald C Elgersma, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract 2934: BYON4228, an antagonistic SIRPα mAb with a unique and favorable preclinical profile compared to three comparator SIRPα mAbs
2023 · Mary van Helden, Seline Zwarthoff, et al. · Cancer Research
Works count: 31
Citation count: 3,306
H-index: 13
I10-index: 14
Year
Topic
Type